These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Involvement of the multiple tumor suppressor genes and 12-lipoxygenase in human prostate cancer. Therapeutic implications. Gao X; Porter AT; Honn KV Adv Exp Med Biol; 1997; 407():41-53. PubMed ID: 9321930 [TBL] [Abstract][Full Text] [Related]
4. PinX1: a sought-after major tumor suppressor at human chromosome 8p23. Zhou XZ Oncotarget; 2011 Oct; 2(10):810-9. PubMed ID: 22021332 [TBL] [Abstract][Full Text] [Related]
5. Frequent loss of heterozygosity on chromosome 10p15, a putative telomerase repressor/senescence gene locus, in gastric cancer. Hiyama T; Tanaka S; Shima H; Kose K; Kitadai Y; Ito M; Sumii M; Yoshihara M; Shimamoto F; Haruma K; Chayama K Oncol Rep; 2003; 10(5):1297-9. PubMed ID: 12883696 [TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of telomerase activity and some tumor markers in non-small cell lung cancer. Hashim M; Sayed M; Samy N; Elshazly S Med Oncol; 2011 Mar; 28(1):322-30. PubMed ID: 20146105 [TBL] [Abstract][Full Text] [Related]
7. Expression of telomerase & its significance in the diagnosis of pancreatic cancer. Zisuh AV; Han TQ; Zhan SD Indian J Med Res; 2012; 135(1):26-30. PubMed ID: 22382179 [TBL] [Abstract][Full Text] [Related]
9. Lysyl oxidase is a tumor suppressor gene inactivated by methylation and loss of heterozygosity in human gastric cancers. Kaneda A; Wakazono K; Tsukamoto T; Watanabe N; Yagi Y; Tatematsu M; Kaminishi M; Sugimura T; Ushijima T Cancer Res; 2004 Sep; 64(18):6410-5. PubMed ID: 15374948 [TBL] [Abstract][Full Text] [Related]
10. Telomerase detection in the diagnosis and prognosis of cancer. Hiyama E; Hiyama K Cytotechnology; 2004 Jun; 45(1-2):61-74. PubMed ID: 19003244 [TBL] [Abstract][Full Text] [Related]
11. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
12. Impact of loss of heterozygosity of encoding phosphate and tensin homolog on the prognosis of gastric cancer. Oki E; Kakeji Y; Baba H; Tokunaga E; Nakamura T; Ueda N; Futatsugi M; Yamamoto M; Ikebe M; Maehara Y J Gastroenterol Hepatol; 2006 May; 21(5):814-8. PubMed ID: 16704528 [TBL] [Abstract][Full Text] [Related]
13. Loss of heterozygosity as a predictor to map tumor suppressor genes in cancer: molecular basis of its occurrence. Thiagalingam S; Foy RL; Cheng KH; Lee HJ; Thiagalingam A; Ponte JF Curr Opin Oncol; 2002 Jan; 14(1):65-72. PubMed ID: 11790983 [TBL] [Abstract][Full Text] [Related]
14. The telomerase inhibitor PinX1 is a major haploinsufficient tumor suppressor essential for chromosome stability in mice. Zhou XZ; Huang P; Shi R; Lee TH; Lu G; Zhang Z; Bronson R; Lu KP J Clin Invest; 2011 Apr; 121(4):1266-82. PubMed ID: 21436583 [TBL] [Abstract][Full Text] [Related]
15. Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma. Engelhardt M; Albanell J; Drullinsky P; Han W; Guillem J; Scher HI; Reuter V; Moore MA Clin Cancer Res; 1997 Oct; 3(10):1849-57. PubMed ID: 9815573 [TBL] [Abstract][Full Text] [Related]
16. Detection of bladder cancer in urine by a tumor suppressor gene hypermethylation panel. Dulaimi E; Uzzo RG; Greenberg RE; Al-Saleem T; Cairns P Clin Cancer Res; 2004 Mar; 10(6):1887-93. PubMed ID: 15041703 [TBL] [Abstract][Full Text] [Related]
17. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation. Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529 [TBL] [Abstract][Full Text] [Related]
18. Correlation analysis between loss of heterozygosity at chromosome 18q and prognosis in the stage-II colon cancer patients. Wang W; Li YF; Sun XW; Chen G; Zhan YQ; Huang CY; Wan DS; Pan ZZ; Zhou ZW Chin J Cancer; 2010 Aug; 29(8):761-7. PubMed ID: 20663324 [TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers. Huang Y; Boynton RF; Blount PL; Silverstein RJ; Yin J; Tong Y; McDaniel TK; Newkirk C; Resau JH; Sridhara R; Reid BJ; Meltzer SJ Cancer Res; 1992 Dec; 52(23):6525-30. PubMed ID: 1423299 [TBL] [Abstract][Full Text] [Related]
20. Characterization and clinical evaluation of microsatellite instability and loss of heterozygosity in tumor-related genes in gastric cancer. Huo X; Xiao X; Zhang S; Du X; Li C; Bai Z; Chen Z Oncol Lett; 2021 Jun; 21(6):430. PubMed ID: 33868468 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]